Cracking rare disorders: a new minimally invasive RNA-seq protocol

RNA sequencing (RNA-seq) has become key to complementing exome and genome sequencing for variant interpretation. We present a minimally invasive RNA-seq protocol using short-term cultured peripheral blood mononuclear cells (PBMCs) with and without cycloheximide treatment, enabling detection of transcripts subject to nonsense-mediated decay. While broadly applicable, this protocol is particularly suited for neurodevelopmental disorders, as up to 80% of the genes in our intellectual disability and epilepsy gene panel are expressed in PBMCs. Applied to 46 affected individuals and 15 parents, RNA-seq revealed splicing defects in six of nine individuals with splice variants, allowing reclassification of seven variants. Targeted cDNA analysis confirmed aberrant splicing in four individuals but missed intron retention in two. Global analyses (FRASER, OUTRIDER, and monoallelic expression) supported findings but did not yield new diagnoses. We propose a flowchart integrating RNA-seq into diagnostic workflows. Overall, our protocol is easily implementable, captures complex splicing events, and enhances variant classification.

Authors

Institutions

Publication Details

Journal
npj Genomic Medicine
Published
2025-05-28
DOI
https://doi.org/10.1038/s41525-025-00502-7
Citations
5
Primary Topic
RNA Research and Splicing
Type
article
Field-Weighted Citation Impact
4.03

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cracking rare disorders: a new minimally invasive RNA-seq protocol

Lynn Backers, Bart Vandekerckhove, Laurenz De Cock, Bert Callewaert et al.
5 citations
npj Genomic Medicine
RNA Research and Splicing
4.03
article

Cracking rare disorders: a new minimally invasive RNA-seq protocol

Lynn Backers, Bart Vandekerckhove, Laurenz De Cock, Bert Callewaert, Kathleen Claes, Jo Sourbron, Hannes Syryn, Nika Schuermans, Sarah Vergult, Simon J. Tavernier, Robin De Putter, Candy Kumps, Erika D’haenens, Griet De Clercq, Björn Menten, Lies Vantomme, Aude Beyens, Olivier Vanakker, Tim Van Damme, Annelies Dheedene, Eva Vanbelleghem
article en
5 citations

Abstract

RNA sequencing (RNA-seq) has become key to complementing exome and genome sequencing for variant interpretation. We present a minimally invasive RNA-seq protocol using short-term cultured peripheral blood mononuclear cells (PBMCs) with and without cycloheximide treatment, enabling detection of transcripts subject to nonsense-mediated decay. While broadly applicable, this protocol is particularly suited for neurodevelopmental disorders, as up to 80% of the genes in our intellectual disability and epilepsy gene panel are expressed in PBMCs. Applied to 46 affected individuals and 15 parents, RNA-seq revealed splicing defects in six of nine individuals with splice variants, allowing reclassification of seven variants. Targeted cDNA analysis confirmed aberrant splicing in four individuals but missed intron retention in two. Global analyses (FRASER, OUTRIDER, and monoallelic expression) supported findings but did not yield new diagnoses. We propose a flowchart integrating RNA-seq into diagnostic workflows. Overall, our protocol is easily implementable, captures complex splicing events, and enhances variant classification.

npj Genomic MedicineVol. 10(1)
Ghent University Hospital (BE), Ghent University (BE), Cancer Research Institute Ghent (BE)
Fonds Wetenschappelijk Onderzoek, Universiteit Gent, Vlaamse regering, Bijzonder Onderzoeksfonds UGent
Zero hunger
Openalex Percentile: Top 6%
RNA Research and Splicing
4.03
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.